NCT02804750View on ClinicalTrials.gov

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Cushing's Syndrome
Interventions
DRUG

CORT125134

Trial Locations (25)

10016

New York

15212

Pittsburgh

23119

Richmond

33136

Miami

33312

Fort Lauderdale

41011

Covington

44195

Cleveland

46202

Indianapolis

55905

Rochester

63110

St Louis

80045

Aurora

92653

Laguna Hills

Unknown

Budapest

Pécs

Cuneo

Messina

Milan

Naples

Orbassano

Roma

Siena

Torino

Leiden

Rotterdam

Salford

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY